VAX2012Q

BIOLOGICAL3 trials

Sponsors

VaxInnate Corporation

Conditions

Influenza

Phase 1

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

VaxInnate CorporationInfluenza

Start: 2014-03-31End: 2015-12-31Updated: 2015-03-06

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

VaxInnate CorporationInfluenza

Start: 2014-11-30End: 2016-03-31Target: 200Updated: 2015-04-17

Phase 2

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

VaxInnate CorporationInfluenza

Start: 2015-05-31End: 2016-06-30Target: 450Updated: 2015-06-26